Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Daewoong Pharmaceutical Co. LTD."
Count: 155
Selected: 0
NCT IDTitle
NCT01634308Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
NCT04782505Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers
NCT04294251Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
NCT05614752Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
NCT05083299Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate
NCT05614778Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis
NCT05614765Study to Evaluate the Management Status of Dyslipidemia Following Administration of Statin and Ezetimibe Complex Treatment Patient
NCT04120753Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab
NCT05607589The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
NCT05376969Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
NCT05376930Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
NCT04634500The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
NCT04632862The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
NCT05574374Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
NCT05466643A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus
NCT05505994The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
NCT05500898Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults
NCT05389215Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
NCT05465668Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C
NCT05414591Pharmacokinetics and Safety Following Administration of DWP16001
NCT05192395A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
NCT04521296Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
NCT05411887Observational Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
NCT03485534Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients
NCT05410535To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
NCT05378360DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
NCT05321732The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults
NCT04654390The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
NCT05304845Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
NCT05226533Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
NCT05207176Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities
NCT05184179Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
NCT04926623Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)
NCT03009487A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
NCT04341454Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
NCT04749173To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.
NCT05149274Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
NCT05072938Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
NCT04888715To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers
NCT04541485To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
NCT04328766Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers
NCT04767815To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers
NCT04888728To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
NCT04827472Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers
NCT04819932Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
NCT04784910Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
NCT04713176Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients
NCT04772443Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507
NCT04721535A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
NCT04613895Treatment Effect According to Timing of Administration of DWP14012 40 mg